<DOC>
	<DOCNO>NCT02432157</DOCNO>
	<brief_summary>Subarachnoid hemorrhage ( SAH ) occur rupture cerebral aneurysm . Treatment SAH focus avoid medical complication include cerebral vasospasm , may result limited circulation brain . Cerebral vasospasm , thin artery brain , fear complication could potentially cause stroke bad outcomes SAH . Hypertonic saline ( HTS ) compound may use prevent vasospasm follow SAH enhance circulation brain . This study evaluate protocol volume expansion HTS safe effective patient subarachnoid hemorrhage prevention cerebral vasospasm .</brief_summary>
	<brief_title>Safety Feasibility Hypertonic Saline Solution After Aneurysmal Subarachnoid Hemorrhage :</brief_title>
	<detailed_description>This prospective , single-center , interventional , randomize , parallel , two-arm ( 1:1 ) phase II clinical trial blind end-point ascertainment design determine safety feasibility protocol 3 % hypertonic saline ( HTS ) `` volume expander '' administer within 72-hours admission 7-days SAH patient compare standard fluid management , individual aneurysmal SAH . A common sequela aneurysmal SAH vasospasm , cause significant morbidity mortality . In addition , 30 % patient SAH develop hypovolemic hyponatremia ( serum sodium [ Na ] &lt; 130mEq/L ) , predispose develop cerebral ischemia . Current guideline management aneurysmal SAH recommend : ( 1 ) maintain euvolemia order prevent delay cerebral ischemia ( DCI ) ( 2 ) use HTS treatment option prevention treatment hypovolemic hyponatremia . Treatment vasospasm include induction hypertension , along systemic and/or intra-arterial administration calcium channel blocker , angioplasty . The investigator ( 1 ) measure incidence severe adverse event protocol HTS , ( 2 ) measure incidence cerebral vasospasm patient treat protocol HTS compare patient treated standard fluid therapy ; ( 3 ) ass burden hypovolemic hyponatremia .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Subarachnoid Hemorrhage</mesh_term>
	<mesh_term>Hyponatremia</mesh_term>
	<mesh_term>Vasospasm , Intracranial</mesh_term>
	<criteria>1 . Age 18 70 inclusive 2 . HuntHess score 15 3 . Glascow Come Scale 415 4 . Modified Fisher Grade 14 5 . At least one reactive pupil 6 . A brain CT/ MRI demonstrate SAH 7 . DSA ( digital subtraction angiogram ) CTA confirm presence intracranial aneurysm 8 . The patient start HTS within 72 hour onset symptom SAH 9 . Previously place central line indication central line placement 1 . Pregnancy , inability rule pregnancy pregnancy test 2 . A normal head CT scan CT scan show bleed SAH 3 . Spinal cord injury serious noncerebral injury 4 . Known seizure disorder 5 . Known brain disease ( eg tumor , metastasis ) major psychiatric disorder ( eg schizophrenia ) 6 . Renal insufficiency ( baseline Cr &gt; 1.5 mg/dl , CrCl &lt; 30 ml/min , CKD ) 7 . Acute systolic dysfunction congestive heart failure ( CHF ) , EF &lt; 30 % 8 . Hematologic abnormalities coagulopathy ( PT &gt; 20 , PTT &gt; 50 , INR &gt; 1.5 , bleed time &gt; 10sec ) 9 . Clinically significant cardiovascular , hepatic pulmonary disease , opinion investigator , would compromise patient safety 10 . Other lifethreatening injury compromise patient survival duration study 11 . Patient unlikely available followup 6 month trial conclusion 12 . Any concurrent relevant condition make patient unsuitable participation followup 13 . Serum sodium &gt; 155 mEq/L</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>